Zhang Li-jun, Sun Ming-yu, Ning Bing-bing, Zhang Wen-meng, Chen Gao-feng, Mu Yong-ping, Zhang Hua, Liu Jia, Bian Yan-qin, Liu Ping
Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Chin J Integr Med. 2014 Jul;20(7):516-23. doi: 10.1007/s11655-014-1862-y. Epub 2014 Jun 28.
To investigate the effects of ancient Chinese medical formula Xiayuxue Decoction ([symbols; see text], XYXD) on activation of hepatic stellate cells (HSCs) and defenestration of sinusoidal endothelial cells (SECs) in CCl4-induced fibrotic liver of mice.
High performance liquid chromatography was used to identify the main components of XYXD and control the quality of extraction. C57BL/6 mice were induced liver fibrosis by CCl4 exposure and administered with XYXD for 6 weeks simultaneously. Liver tissue was investigated by hematoxylin-eosin and Sirius-red staining. Sinusoidal fenestrations were observed by scanning electronic microscopy and fluorescent immunohistochemistry of PECAM-1 (CD31). Whole liver lysates were detected of α-smooth muscle actin (α-SMA) and type-I collagen by Western blot. Primary rat HSCs-T6 cells were analyzed by detecting α-SMA, F-actin, DNA fragmentation through confocal microscopy, Western blot, terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) assay and cellomics arrayscan, respectively.
Amygdalin and emodin in XYXD were identified. XYXD (993 mg/kg) inhibited Sirius red positive area up to 70.1% (P<0.01), as well as protein levels of α-SMA and type-I collagen by 42.0% and 18.5% (P<0.05) respectively. In vitro, XYXD (12.5 μg/mL, 50 μg/mL) suppressed the activation of HSCs and reversed the myofibroblastic HSCs into quiescent, demonstrated as inhibition of fluorescent F-actin by 32.3% and 46.6% (P<0.05). Besides, XYXD induced the apoptosis of HSC-T6 cells by 20.0% (P<0.05) and 49.5% (P<0.01), evidenced by enhanced TUNEL positivity. Moreover, ultrastructural observation suggested XYXD inhibited defenestration of SECs, which was confirmed by 31.1% reduction of protein level of CD31 (P<0.05).
XYXD inhibited both HSCs activation and SECs defenestration which accompany chronic liver injuries. These data may help to understand the underlying mechanisms of XYXD for prevetion of chronic liver diseases.
探讨中药古方下瘀血汤(XYXD)对四氯化碳诱导的小鼠肝纤维化模型中肝星状细胞(HSCs)激活及肝血窦内皮细胞(SECs)窗孔减少的影响。
采用高效液相色谱法鉴定XYXD的主要成分并控制提取物质量。C57BL/6小鼠经四氯化碳诱导肝纤维化,同时给予XYXD治疗6周。采用苏木精-伊红染色和天狼星红染色观察肝组织。通过扫描电子显微镜和血小板内皮细胞黏附分子-1(PECAM-1,CD31)荧光免疫组化观察肝血窦窗孔。采用蛋白质印迹法检测全肝裂解液中α-平滑肌肌动蛋白(α-SMA)和I型胶原蛋白。分别通过共聚焦显微镜、蛋白质印迹法、末端脱氧核苷酸转移酶介导的缺口末端标记法(TUNEL)检测及细胞组学阵列扫描分析原代大鼠HSCs-T6细胞中的α-SMA、F-肌动蛋白和DNA片段化情况。
鉴定出XYXD中的苦杏仁苷和大黄素。XYXD(993mg/kg)使天狼星红阳性面积抑制达70.1%(P<0.01),α-SMA和I型胶原蛋白蛋白水平分别降低42.0%和18.5%(P<0.05)。在体外,XYXD(12.5μg/mL、50μg/mL)抑制HSCs激活,并使肌成纤维细胞样HSCs逆转为静止状态,表现为荧光F-肌动蛋白分别抑制32.3%和46.6%(P<0.05)。此外,XYXD使HSC-T6细胞凋亡率分别增加20.0%(P<0.05)和49.5%(P<0.01),TUNEL阳性增强可证明。而且,超微结构观察表明XYXD抑制SECs窗孔减少,CD31蛋白水平降低31.1%证实了这一点(P<0.05)。
XYXD抑制慢性肝损伤时伴随的HSCs激活和SECs窗孔减少。这些数据可能有助于理解XYXD预防慢性肝病的潜在机制。